Viridian Therapeutics EPS VRDN

Diluted earnings per share by quarter and over the last twelve months, from 2013.

Viridian Therapeutics' twelve-month earnings per share can't be added up yet: a quarter of its results is missing from our data.

In its latest quarter, Q2 FY25, it was −$1.23.

Earnings per share over time

Each fiscal year is the twelve months to its fourth quarter.

Quarter	Ended	EPS	On a year earlier	Last 12 months
Q2 FY25	Jun 30, 2025	−$1.23	n/a	n/a
Q1 FY25	Mar 31, 2025	−$1.07	n/a	n/a
Q3 FY24	Sep 30, 2024	−$1.15	n/a	−$4.30
Q2 FY24	Jun 30, 2024	−$1.02	n/a	−$4.24
Q1 FY24	Mar 31, 2024	−$0.79	n/a	−$4.49
Q4 FY23	Dec 31, 2023	−$1.34	n/a	−$5.31
Q3 FY23	Sep 30, 2023	−$1.09	n/a	−$5.10
Q2 FY23	Jun 30, 2023	−$1.27	n/a	−$4.87
Q1 FY23	Mar 31, 2023	−$1.61	n/a	−$4.66
Q4 FY22	Dec 31, 2022	−$1.13	n/a	−$4.03
Q3 FY22	Sep 30, 2022	−$0.86	n/a	−$4.21
Q2 FY22	Jun 30, 2022	−$1.06	n/a	−$4.60

Companies in Drug Manufacturers - General nearest Viridian Therapeutics' size, closest first, today.

Company	EPS, 12 months	Growth
VRDNViridian Therapeutics	n/m
NRIXNurix Therapeutics	$2.31
PBHPrestige Consumer Healthcare	$3.57	−16% a year
HRMYHarmony Biosciences	$3.09	−0% a year
OGNOrganon	$0.77	−71% a year
LQDALiquidia	$1.39
ANIPANI Pharmaceuticals	$4.70
ARQTArcutis Biotherapeutics	$0.22
INDVIndivior Pharmaceuticals	$2.78	+227% a year
PAHCPhibro Animal Health	$2.44	+107% a year
ANABAnaptysbio	$4.57
Peer median	$2.61